PubMed Health⌕ Search

PubMed · 12897596

Statistical sampling and hypothesis testing in orthopaedic research.

Abstract

The purpose of the current article was to review the process of hypothesis testing and statistical sampling and empower readers to critically appraise the literature. When the p value of a study lies above the alpha threshold, the results are said to be not statistically significant. It is possible, however, that real differences do exist, but the study was insufficiently powerful to detect them. In that case, the conclusion that two groups are equivalent is wrong. The probability of this mistake, the Type II error, is given by the beta statistic. The complement of beta, or 1-beta, representing the chance of avoiding a Type II error, is termed the statistical power of the study. We previously examined the statistical power and sample size in all of the studies published in 1997 in the American and British volumes of the Journal of Bone and Joint Surgery, and in Clinical Orthopaedics and Related Research. In the journals examined, only 3% of studies had adequate statistical power to detect a small effect size in this sample. In addition, a study examining only randomized control trials in these journals showed that none of 25 randomized control trials had adequate statistical power to detect a small effect size. However, beta, or power, is less well understood. Because of this, researchers and readers should be aware of the need to address issues of statistical power before a study begins and be cautious of studies that conclude that no difference exists between groups.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Joseph Bernstein, Kevin McGuire, Kevin B Freedman. 2003. Statistical sampling and hypothesis testing in orthopaedic research.. https://doi.org/10.1097/01.blo.0000079769.06654.8c

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Designing an optimum genetic association study using dense SNP markers and family-based sample.

Genetic association analysis using thousands of single nucleotide polymorphism (SNP) markers has become a promising alternative to genome-wide linkage scan. Analysis based on linkage-disequilibrium (LD) is more efficient because meiotic information of past generations is utilized. However, in addition to the physical distance between the disease locus and a marker locus, numerous other factors such as admixture, genetic drift, and multiple mutations can affect the observed value of LD. The effect of these factors in a genomic LD association study must be carefully analyzed to obtain an efficient study design. In the following review, we consider studies using family-based data and carefully study the effects of some of these important design factors, including the sample size, frequency of SNP markers, and marker density. For example, we conclude that (1) for reasonably frequent SNP markers, a moderately large sample of 500 families is appropriate for a moderately stringent significance level (alpha = 0.00009); (2) to maintain a power of 80%, maximal difference in allele frequencies between the disease gene and a SNP marker varies between 0.1 (under additive model) and 0.5 (multiplicative); (3) a map density of 10 cM is appropriate only under idea scenario (moderately large sample size, equal trait/marker allele frequencies, maximum LD strength etc.). Results shown here should have practical implications to designing efficient LD association studies using dense SNP markers.

Epidemiologic Research Design↗